Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance & Responsiveness Improvement for Metformin (TRIM): Open-label, Parallel-group Randomized Trial, Phase 4

NCT03670043 is registered in ClinicalTrials.gov with West Side Institute for Science and Education as lead sponsor.

NCT NCT03670043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03670043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance & Responsiveness Improvement for Metformin (TRIM): Open-label, Parallel-group Randomized Trial, Phase 4
Lead sponsor
West Side Institute for Science and Education
Phase
Phase 4
Overall status
Completed
Start date
March 19, 2019
Completion date
August 15, 2021
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes mellitus